About this document "After and Before CAR-T PET Scans - 2024.PNG": summarize findings

October 15, 2025Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Based on the document title "After and Before CAR-T PET Scans - 2024.PNG", this appears to be a comparison of PET scan images taken before and after CAR-T cell therapy. However, without being able to directly view the actual scan images, I cannot make specific claims about the findings or results shown in these particular scans.

What I can explain, based on authoritative sources, is the general context of PET scanning in CAR-T therapy:

According to NCCN Guidelines for CAR-T cell therapy monitoring:

  • PET scans are a standard imaging tool used to assess response to CAR-T cell therapy
  • They help evaluate disease status before treatment and monitor response afterward

Per the American Society of Clinical Oncology (ASCO) guidelines:

  • PET-CT imaging is typically performed at baseline (pre-treatment)
  • Follow-up scans are conducted at specific intervals post-treatment to assess response
  • Response criteria often follow the Lugano Classification for lymphomas

According to the National Cancer Institute (NCI):

  • PET scans can help detect active cancer cells by showing areas of increased metabolic activity
  • They are particularly useful in monitoring response to immunotherapies like CAR-T

To provide specific findings from these particular scans, I would need to see the actual images. I recommend discussing the specific scan results with your healthcare provider who can interpret the images in the context of your individual case.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: